Management of Angiotensin Inhibitors During the Perioperative Period (AIPOP)
Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers During the Perioperative Period: to Withdraw or to Continue? A Multicenter Randomized Controlled Trial
Sponsor: UMC Utrecht
Terminated
slow recruitment rate
This NA trial investigates Angiotensin Hypertension and Perioperative Complication and is currently terminated or withdrawn. UMC Utrecht leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2023 — Jul 2024 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Jul 2023 — Dec 2023 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Feb 2022 — Jul 2023 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Jan 2021 — Feb 2022 [monthly]
Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- UMC Utrecht
- ZonMw: The Netherlands Organisation for Health Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .